Fig. 2.

Prognostic significance of SOX4 expression in different tumor types. (A–D) Survival curves showing overall survival (OS), progression-free survival (PFS), disease-specific survival (DSS), and relapse-free survival (RFS) in hepatocellular carcinoma (HCC) from the Kaplan–Meier database. (E) UALCAN database estimates of OS in patients with liver hepatocellular carcinoma (LIHC) from TCGA database. (F–I) Subgroup analysis for body weight (F), tumor grade (G), sex (H), and race (I) in the UALCAN database “survival analysis” module. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, NC: not significant